Immune Checkpoints of the B7 Family. Part 1. General Characteristics and First Representatives: B7-1, B7-2, B7-H1, B7-H2, and B7-DC

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Russian journal of bioorganic chemistry

• Publication date

  2019-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1134/S1068162019040101
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?

  2018cited by this paper
• Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations

  2018cited by this paper
• The prognostic value and pathobiological significance of Glasgow microenvironment score in gastric cancer

  2017cited by this paper
• Cancer immunotherapies targeting the PD-1 signaling pathway

  2017cited by this paper
• Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus

  2016cited by this paper
• Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.

  2016cited by this paper
• Confusing signals: Recent progress in CTLA-4 biology

  2015cited by this paper
• Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

  2015cited by this paper
• Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites

  2015cited by this paper
• ИММУНОТЕРАПИЯ ОПУХОЛЕЙ, ОСНОВАННАЯ НА БЛОКИРОВКЕ ИММУНОЛОГИЧЕСКИХ КОНТРОЛЬНЫХ «ТОЧЕК» («ЧЕКПОЙНТОВ»)

  2015cited by this paper
• Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.

  2015cited by this paper
• Pembrolizumab versus Ipilimumab in Advanced Melanoma.

  2015cited by this paper
• Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.

  2014cited by this paper
• Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.

  2014cited by this paper
• Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy

  2014cited by this paper
• Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain

  2014cited by this paper
• MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

  2014cited by this paper
• Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells

  2014cited by this paper
• Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.

  2013cited by this paper
• Molecular mechanisms of T cell co-stimulation and co-inhibition

  2013cited by this paper
• The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer

  2013cited by this paper
• Nivolumab plus ipilimumab in advanced melanoma.

  2013cited by this paper
• Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

  2012cited by this paper
• Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

  2012cited by this paper
• Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.

  2011cited by this paper
• Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4

  2011cited by this paper
• Host APCs Augment In Vivo Expansion of Donor Natural Regulatory T Cells via B7H1/B7.1 in Allogeneic Recipients

  2011cited by this paper
• B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.

  2010cited by this paper
• Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.

  2009cited by this paper
• B7RP-1 Blockade Ameliorates Autoimmunity through Regulation of Follicular Helper T Cells

  2009cited by this paper
• Inhibitory B7-family molecules in the tumour microenvironment

  2008cited by this paper
• B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation.

  2008cited by this paper
• Effector Functions of Donor‐Reactive CD8 Memory T Cells Are Dependent on ICOS Induced During Division in Cardiac Grafts

  2008cited by this paper
• Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.

  2008cited by this paper
• Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.

  2007cited by this paper
• Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.

  2006cited by this paper
• T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor.

  2006cited by this paper
• Tissue expression of PD-L1 mediates peripheral T cell tolerance

  2006cited by this paper
• Impaired Regulatory T-Cell Response and Enhanced Atherosclerosis in the Absence of Inducible Costimulatory Molecule

  2006cited by this paper
• ICOS Deficiency Is Associated with a Severe Reduction of CXCR5+CD4 Germinal Center Th Cells1

  2006cited by this paper
• In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses

  2005cited by this paper
• The Role of ICOS in the CXCR5+ Follicular B Helper T Cell Maintenance In Vivo1

  2005cited by this paper
• © 2005 BioMed Central Ltd Summary

  2005cited by this paper
• Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.

  2005cited by this paper
• Role of B7 Costimulatory Molecules in Mediating Systemic and Mucosal Antibody Responses to Attenuated Salmonella enterica Serovar Typhimurium and Its Cloned Antigen

  2004cited by this paper
• B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 Expression

  2004cited by this paper
• Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection.

  2004cited by this paper
• CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86

  2004cited by this paper
• The Inducible Costimulator Plays the Major Costimulatory Role in Humoral Immune Responses in the Absence of CD28 1

  2004cited by this paper
• Cloning and identification of two novel splice variants of human PD-L2.

  2004cited by this paper
• The role of ICOS and other costimulatory molecules in allergy and asthma

  2004cited by this paper
• Inducible-costimulator-mediated suppression of human immunodeficiency virus type 1 replication in CD4(+) T lymphocytes.

  2004cited by this paper
• Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

  2003cited by this paper
• The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice

  2003cited by this paper
• B7h is required for T cell activation, differentiation, and effector function

  2003cited by this paper
• Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis.

  2003cited by this paper
• Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis

  2003cited by this paper
• Molecular Modeling and Functional Mapping of B7-H1 and B7-DC Uncouple Costimulatory Function from PD-1 Interaction

  2003cited by this paper
• Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

  2003cited by this paper
• Impaired germinal center formation and recall T-cell-dependent immune responses in mice lacking the costimulatory ligand B7-H2.

  2003cited by this paper
• Inducible costimulator is essential for collagen-induced arthritis.

  2003cited by this paper
• Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation 1

  2003cited by this paper
• Involvement of ICOS-B7RP-1 costimulatory pathway in the regulation of immune responses to Leishmania major and Nippostrongylus brasiliensis infections.

  2003cited by this paper
• Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss.

  2003cited by this paper
• PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

  2003cited by this paper
• Regulation of immune and autoimmune responses by ICOS.

  2003cited by this paper
• Preferential contribution of B7‐H1 to programmed death‐1‐mediated regulation of hapten‐specific allergic inflammatory responses

  2003cited by this paper
• Expression of Programmed Death 1 Ligands by Murine T Cells and APC1

  2002cited by this paper
• Structural mechanisms of costimulation

  2002cited by this paper
• Cutting Edge: Inducible Costimulator Protein Regulates Both Th1 and Th2 Responses to Cutaneous Leishmaniasis1

  2002cited by this paper
• B7-H1 Is Expressed by Human Endothelial Cells and Suppresses T Cell Cytokine Synthesis1

  2002cited by this paper
• Amelioration of Collagen-Induced Arthritis by Blockade of Inducible Costimulator-B7 Homologous Protein Costimulation1

  2002cited by this paper
• Role of ICOS versus CD28 in antiviral immunity

  2002cited by this paper
• The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE

  2001cited by this paper
• PD-L2 is a second ligand for PD-1 and inhibits T cell activation

  2001cited by this paper
• Differential Expression of Inducible Costimulator-Ligand Splice Variants: Lymphoid Regulation of Mouse GL50-B and Human GL50 Molecules

  2001cited by this paper
• Importance of ICOS–B7RP-1 costimulation in acute and chronic allograft rejection

  2001cited by this paper
• ICOS co-stimulatory receptor is essential for T-cell activation and function

  2001cited by this paper
• ICOS is critical for CD40-mediated antibody class switching

  2001cited by this paper
• Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches.

  2001cited by this paper
• Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.

  2001cited by this paper
• ICOS is essential for effective T-helper-cell responses

  2001cited by this paper
• B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells

  2001cited by this paper
• Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor

  2000cited by this paper
• Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand

  2000cited by this paper
• Inducible Costimulator Protein (Icos) Controls T Helper Cell Subset Polarization after Virus and Parasite Infection

  2000cited by this paper
• Follicular B Helper T Cells Express Cxc Chemokine Receptor 5, Localize to B Cell Follicles, and Support Immunoglobulin Production

  2000cited by this paper
• Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family.

  2000cited by this paper
• Regulation of Cell Surface Expression of CTLA-4 by Secretion of CTLA-4-Containing Lysosomes Upon Activation of CD4+ T Cells1

  2000cited by this paper
• Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T Cells1

  2000cited by this paper
• Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS

  2000cited by this paper
• Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function

  2000cited by this paper
• Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

  2000cited by this paper
• The DNA sequence of human chromosome 21

  2000cited by this paper
• LICOS, a primordial costimulatory ligand?

  2000cited by this paper
• Induction, binding specificity and function of human ICOS

  2000cited by this paper
• The CD28-related molecule ICOS is required for effective T cell-dependent immune responses.

  2000cited by this paper
• B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha.

  1999cited by this paper
• ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

  1999cited by this paper
• B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

  1999cited by this paper

• Chemotherapy resistance in acute myeloid leukemia is associated with decreased anti-tumor immune response through MHC molecule and B7 family members

  2024cites this paper
• B7 immune checkpoint family members as putative therapeutics in autoimmune disease: An updated overview

  2022cites this paper
• Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy

  2022cites this paper
• Peptide Blocking CTLA-4 and B7-1 Interaction

  2021cites this paper
• The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review

  2021cites this paper
• Soluble B7-H3 in Ovarian Cancer and Its Predictive Value

  2021cites this paper